Marketing attribution vs the traditional approach: what actually beats what for healthcare and life sciences

This edition is written for commercial leaders at healthtech, medtech, and life-sciences companies. In healthcare and life sciences, healthcare buyers move under regulatory constraint and reward domain-specific messaging, so the way you install marketing attribution has to reflect that reality from day one.

The debate about marketing attribution is often framed as replacement — new model wipes out old. That framing is wrong. The right question is where each approach wins.

Marketing attribution wins on speed of learning, targeting precision, and cost per outcome. It is the honest answer to which activities create pipeline, and it compounds in ways the traditional approach cannot match.

The traditional approach wins on relationship depth, brand consistency, and situations where the buyer has already self-identified. Ignoring that is why some teams' first marketing attribution attempt underperforms — they replace the wrong parts.

The binding constraint we see in healthcare and life sciences is almost always regulated-sale cycle length, not intent. Marketing attribution is only useful in this vertical when it is pointed at that constraint — not at a generic growth number borrowed from another category.

Combine them deliberately. Use marketing attribution to find and qualify; use the traditional approach to close and expand. The seam between them is where most pipeline is lost or won.

Metric to watch when running both: attribution model reconciled to closed-won, plus source attribution. The two approaches should not cannibalise each other; if they do, your handoff is broken.

The failure mode of running both is picking a model to defend a budget instead of to learn — usually because the traditional team feels threatened and the new model is starved of context.

Companies that get this right end up with a hybrid engine that outperforms either pure model. Companies that pick one and evangelise it lose to the ones that combine.

Concretely for healthcare and life sciences: the healthcare teams that install this get past procurement instead of dying in it. That is the reason it is worth installing marketing attribution properly rather than half-heartedly across three vendors.